The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
The EMBO Journal (1997) 16, 6737–6747, doi:10.1093/emboj/16.22.6737
Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor
Ulrik Gether1, 4, Sansan Lin1, Pejman Ghanouni1, Juan A. Ballesteros3, Harel Weinstein3 and Brian K. Kobilka1, 2
1 Howard Hughes Medical Institute, Stanford University Medical School, Stanford, CA 94305 USA
2 Division of Cardiovascular Medicine, Stanford University Medical School, Stanford, CA 94305 USA
3 Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York, NY 10029, USA
4 Present address: Department of Medical Physiology, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark

To whom correspondence should be addressed

Ulrik Gether, gether@mfi.ku.dk
Brian K. Kobilka, kobilka@cmgm.stanford.edu

Received 18 April 1997; Revised 28 July 1997.
Abstract
Agonist binding to G protein-coupled receptors is believed to promote a conformational change that leads to the formation of the active receptor state. However, the character of this conformational change which provides the important link between agonist binding and G protein coupling is not known. Here we report evidence that agonist binding to the beta2 adrenoceptor induces a conformational change around 125Cys in transmembrane domain (TM) III and around 285Cys in TM VI. A series of mutant beta2 adrenoceptors with a limited number of cysteines available for chemical derivatization were purified, site-selectively labeled with the conformationally sensitive, cysteine-reactive fluorophore IANBD and analyzed by fluorescence spectroscopy. Like the wild-type receptor, mutant receptors containing 125Cys and/or 285Cys showed an agonist-induced decrease in fluorescence, while no agonist-induced response was observed in a receptor where these two cysteines were mutated. These data suggest that IANBD bound to 125Cys and 285Cys are exposed to a more polar environment upon agonist binding, and indicate that movements of transmembrane segments III and VI are involved in activation of G protein-coupled receptors.
Keywords: fluorescence spectroscopy, G protein-coupled receptors, molecular modeling, signal transduction
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 1997 by the European Molecular Biology Organization